動物腎疾患の世界市場：市場規模・シェア・動向分析 (製品種類別・動物の種類別・投与経路別・適応症別・流通チャネル別・地域別)、セグメント別予測 (2025年～2030年)

動物腎疾患市場の成長と動向：

Grand View Research社の最新レポートによると、世界の動物腎疾患の市場規模は2030年までに248億5,000万米ドルに達すると予測されています。

同市場は2025年から2030年にかけてCAGR 6.7％で成長すると予測されています。腎疾患の有病率の上昇と治療としての治療食の採用が、この市場の主要な成長促進要因です。慢性腎臓病（CKD）、腎不全などの腎疾患は、動物の腎系に不可逆的な損傷を与えます。この病気には明確な治療法がないにもかかわらず、さまざまな種類の治療法によって適切に管理することで、動物の生命を向上させることができます。最も顕著な方法のひとつは、療法食による栄養管理です。

もう一つの重要な市場推進力は、動物腎疾患の診断と治療におけるAIの採用が増加していることです。画像診断は、病気や傷害の評価だけでなく、定期的な予防措置に不可欠なデータを提供することで、獣医学において重要な役割を果たしています。AIは、特に放射線科医が不足している地域において、非常に有益なツールであることが証明できます。より迅速で強化された診断能力などの関連する利点は、AIの採用を増加させ、それによって近い将来の市場にプラスの影響を与えると予想されます。

動物医療分野で著名なマース社は、AIを動物用診断・治療に応用する分野に既に参入しています。アンテック・ダイアグノスティックス（マース社）は2019年に最先端の診断ツールであるRenalTechを発表しました。RenalTechは人工知能（AI）を使ってペットのカルテデータを評価し、確立された臨床診断よりも最大2年先まで猫の慢性腎臓病（CKD）発症リスクを予測します。

さらに、製品ポートフォリオの拡大、M&A、統合活動などの市場力学は、この市場に成長基盤を提供すると予想されます。例えば、2023年9月、エランコ・アニマル・ヘルス社は、慢性腎臓病（CKD）の猫における非再生性貧血の治療薬として、Varenzin-CA1（molidustat経口懸濁液）の条件付き承認を米国FDAから取得しました。さらに2023年12月、ネオジェン・コーポレーションはフロリダ州ミャッカシティにあるTerraNova Equestrian Centerと提携し、診断検査製品について同施設の公式バイオセキュリティプロバイダーとなりました。

動物腎疾患市場レポートハイライト

• 種類別では、治療分野が2024年に68.96%の最大売上シェアで市場をリード。これは、世界のペット数の増加に加えて、利用可能な治療法が豊富なためです。
• 動物の種類別では、ネコのセグメントが予測期間中に最も速いCAGRで成長すると予想されます。
• 投与経路別では、経口剤が2024年に最大の収益シェアを占め、注射剤が予測期間中に最も速いCAGRで成長すると予測されます。
• 適応症に基づくと、腎膀胱炎セグメントは2024年に29.05％の最大の収益シェアを占め、腎炎セグメントは予測期間中に2番目に速いCAGRを有すると予想されます。
• 動物における様々な腎合併症の有病率の上昇、ペットフードの顕著な使用、疾患啓発イニシアチブの高まりが市場成長に寄与しています。
• 北米は、2024年の市場で最大の収益シェアを占めています。この地域全体で動物医療全般の重要性が高まっていることが、市場拡大を推進する重要な要因として認識されています。米国ペット用品協会は、2023-2024年に同国でペットを飼っている家庭は6,510万戸に上ると推定しています。さらに、動物の健康に対する飼い主の意識の高まりと、腎障害を持つ動物にケアを提供することの重要性が、北米での市場拡大に拍車をかけています。
• 2024年5月、デクラ・ファーマシューティカルズはシニア猫の腎臓の健康をサポートする2つの製品、Porus OneとAdd Oneの販売権を発表しました。Porus Oneは、選択的吸収剤であるrenaltecを含有しており、通常であれば健康な腎臓によって除去または調節される尿毒症毒素の前駆物質を猫の腸内で吸収します。Add Oneは、シニア猫用に開発されたしっとりタイプの猫用おやつで、Porus Oneを食べてもらうために開発され、ドライフードを好む猫にも有用と言われています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 動物腎疾患市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
  • 市場機会の分析
  • 市場の課題の分析
• 動物腎疾患市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
• 価格分析（2024年）
• COVID-19の分析

第4章 動物腎疾患市場：製品種類別の推定・動向分析

• セグメントダッシュボード
• 世界の動物腎疾患市場の変動分析
• 世界の動物腎疾患の市場規模と動向分析：製品種類別（2018～2030年）
• 診断
  • テストキット・消耗品
  • 装置
• 治療
  • 薬剤
  • 治療用食品サプリメント
  • リンゲル乳酸液

第5章 動物腎疾患市場：動物の種類別の推定・動向分析

• セグメントダッシュボード
• 世界の動物腎疾患市場の変動分析
• 世界の動物腎疾患の市場規模と動向分析：動物の種類別（2018～2030年）
• イヌ科
• ネコ科
• 牛
• 馬
• その他

第6章 動物腎疾患市場：投与経路別の推定・動向分析

• セグメントダッシュボード
• 世界の動物腎疾患市場の変動分析
• 世界の動物腎疾患の市場規模と動向分析：投与経路別（2018～2030年）
• 経口剤
• 注射剤

第7章 動物腎疾患市場：適応症別の推定・動向分析

• セグメントダッシュボード
• 世界の動物腎疾患市場の変動分析
• 世界の動物腎疾患の市場規模と動向分析：適応症別（2018～2030年）
• 腎不全
• 慢性腎臓病（CKD）
• 腎性膀胱炎
• 腎臓結石
• 腎炎
• その他

第8章 動物腎疾患市場：流通チャネル別の推定・動向分析

• セグメントダッシュボード
• 世界の動物腎疾患市場の変動分析
• 世界の動物腎疾患の市場規模と動向分析：流通チャネル別（2018～2030年）
• 動物病院・クリニック
• ペット専門店
• eコマース
• その他

第9章 動物腎疾患市場：地域別の推定・動向分析

• 地域別ダッシュボード
• 北米の市場規模の予測と動向分析（2018～2030年）
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • デンマーク
  • ノルウェー
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 市場参入企業の分類
• 企業の市況分析/ヒートマップ分析
• 企業別市場シェアの予測分析（2024年）
• 戦略マッピング
  • 企業合併・買収 (M&A)
  • 事業提携・協力
  • その他
• 企業プロファイル
  • Mars, Incorporated
  • Nestle Purina PetCare
  • Arkray
  • General Mills
  • Zoetis Inc.
  • Merck &Co., Inc.
  • Elanco
  • Bionote USA
  • Ceva Sante Animale
  • Boehringer Ingelheim International GmbH.
  • Dechra Pharmaceuticals PLC
  • Vedco Inc.
  • Mission Pharmacal Company
  • Neogen Corporation
  • IDEXX Laboratories, Inc.

第11章 重要なポイント

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 4 Global Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 5 Global Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 6 Global Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 7 Global Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 8 Global Veterinary Renal Disease Market, by Region, 2018 - 2030 (USD Billion)
• Table 9 North America Veterinary Renal Disease Market, by Country, 2018 - 2030 (USD Billion)
• Table 10 North America Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 11 North America Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 12 North America Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 13 North America Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 14 North America Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 15 U.S. Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 16 U.S. Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 17 U.S. Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 18 U.S. Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 19 U.S. Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 20 Canada Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 21 Canada Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 22 Canada Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 23 Canada Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 24 Canada Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 25 Mexico Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 26 Mexico Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 27 Mexico Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 28 Mexico Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 29 Mexico Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 30 Europe Veterinary Renal Disease Market, by Country, 2018 - 2030 (USD Billion)
• Table 31 Europe Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 32 Europe Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 33 Europe Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 34 Europe Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 35 Europe Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 36 Germany Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 37 Germany Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 38 Germany Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 39 Germany Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 40 Germany Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 41 UK Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 42 UK Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 43 UK Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 44 UK Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 45 UK Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 46 France Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 47 France Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 48 France Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 49 France Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 50 France Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 51 Italy Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 52 Italy Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 53 Italy Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 54 Italy Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 55 Italy Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 56 Spain Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 57 Spain Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 58 Spain Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 59 Spain Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 60 Spain Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 61 Denmark Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 62 Denmark Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 63 Denmark Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 64 Denmark Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 65 Denmark Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 66 Sweden Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 67 Sweden Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 68 Sweden Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 69 Sweden Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 70 Sweden Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 71 Norway Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 72 Norway Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 73 Norway Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 74 Norway Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 75 Norway Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 76 Asia Pacific Veterinary Renal Disease Market, by Country, 2018 - 2030 (USD Billion)
• Table 77 Asia Pacific Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 78 Asia Pacific Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 79 Asia Pacific Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 80 Asia Pacific Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 81 Asia Pacific Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 82 China Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 83 China Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 84 China Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 85 China Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 86 China Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 87 Japan Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 88 Japan Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 89 Japan Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 90 Japan Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 91 Japan Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 92 India Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 93 India Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 94 India Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 95 India Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 96 India Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 97 South Korea Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 98 South Korea Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 99 South Korea Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 100 South Korea Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 101 South Korea Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 102 Australia Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 103 Australia Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 104 Australia Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 105 Australia Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 106 Australia Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 107 Thailand Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 108 Thailand Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 109 Thailand Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 110 Thailand Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 111 Thailand Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 112 Latin America Veterinary Renal Disease Market, by Country, 2018 - 2030 (USD Billion)
• Table 113 Latin America Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 114 Latin America Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 115 Latin America Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 116 Latin America Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 117 Latin America Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 118 Brazil Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 119 Brazil Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 120 Brazil Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 121 Brazil Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 122 Brazil Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 123 Argentina Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 124 Argentina Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 125 Argentina Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 126 Argentina Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 127 Argentina Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 128 Middle East & Africa Veterinary Renal Disease Market, by Country, 2018 - 2030 (USD Billion)
• Table 129 Middle East & Africa Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 130 Middle East & Africa Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 131 Middle East & Africa Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 132 Middle East & Africa Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 133 Middle East & Africa Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 134 South Africa Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 135 South Africa Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 136 South Africa Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 137 South Africa Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 138 South Africa Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 139 Saudi Arabia Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 140 Saudi Arabia Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 141 Saudi Arabia Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 142 Saudi Arabia Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 143 Saudi Arabia Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 144 UAE Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 145 UAE Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 146 UAE Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 147 UAE Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 148 UAE Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 149 Kuwait Veterinary Renal Disease Market, by Product Type, 2018 - 2030 (USD Billion)
• Table 150 Kuwait Veterinary Renal Disease Market, by Animal Type, 2018 - 2030 (USD Billion)
• Table 151 Kuwait Veterinary Renal Disease Market, by Route of Administration, 2018 - 2030 (USD Billion)
• Table 152 Kuwait Veterinary Renal Disease Market, by Indication, 2018 - 2030 (USD Billion)
• Table 153 Kuwait Veterinary Renal Disease Market, by Distribution Channel, 2018 - 2030 (USD Billion)
• Table 154 Company Overview
• Table 155 Service Benchmarking
• Table 156 Financial Performance
• Table 157 Strategic Initiatives

List of Figures

• Fig. 1 Veterinary Renal Disease Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Data Analysis Models
• Fig. 6 Market Formulation And Validation
• Fig. 7 Data Validating & Publishing
• Fig. 8 General methodology for a commodity flow analysis of Veterinary Renal Disease Market
• Fig. 9 Commodity flow analysis
• Fig. 10 Parent market analysis
• Fig. 11 Market Snapshot
• Fig. 12 Segment snapshot
• Fig. 13 Segment snapshot
• Fig. 14 Segment snapshot
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Parent market value, 2024 (USD Billion)
• Fig. 17 Ancillary market outlook, 2024
• Fig. 18 Veterinary Renal Disease Market Dynamics
• Fig. 19 Estimated animal population, 2018-2024 by key species and key countries
• Fig. 20 Veterinary Renal Disease Market: PORTER's analysis
• Fig. 21 Veterinary Renal Disease Market: PESTEL analysis
• Fig. 22 Veterinary Renal Disease Market by Product Type: Key Takeaways
• Fig. 23 Veterinary Renal Disease Market by Product Type, Market Share, 2024 & 2030
• Fig. 24 Diagnosis market, 2018 - 2030 (USD Billion)
• Fig. 25 Test Kits & Consumables market, 2018 - 2030 (USD Billion)
• Fig. 26 Instruments market, 2018 - 2030 (USD Billion)
• Fig. 27 Treatment market, 2018 - 2030 (USD Billion)
• Fig. 28 Drugs market, 2018 - 2030 (USD Billion)
• Fig. 29 NSAIDs market, 2018 - 2030 (USD Billion)
• Fig. 30 Antibiotics market, 2018 - 2030 (USD Billion)
• Fig. 31 Cystine-binding Agents market, 2018 - 2030 (USD Billion)
• Fig. 32 Diuretics market, 2018 - 2030 (USD Billion)
• Fig. 33 Others market, 2018 - 2030 (USD Billion)
• Fig. 34 Therapeutic Food Supplements market, 2018 - 2030 (USD Billion)
• Fig. 35 Ringer Lactate Solution market, 2018 - 2030 (USD Billion)
• Fig. 36 Veterinary Renal Disease Market by Animal Type: Key Takeaways
• Fig. 37 Veterinary Renal Disease Market by Animal Type, 2024 & 2030
• Fig. 38 Canine market, 2018 - 2030 (USD Billion)
• Fig. 39 Feline market, 2018 - 2030 (USD Billion)
• Fig. 40 Bovine market, 2018 - 2030 (USD Billion)
• Fig. 41 Equine market, 2018 - 2030 (USD Billion)
• Fig. 42 Others market, 2018 - 2030 (USD Billion)
• Fig. 43 Veterinary Renal Disease Market by Route of Administration: Key Takeaways
• Fig. 44 Veterinary Renal Disease Market by Route of Administration, 2024 & 2030
• Fig. 45 Oral market, 2018 - 2030 (USD Billion)
• Fig. 46 Injectable market, 2018 - 2030 (USD Billion)
• Fig. 47 Veterinary Renal Disease Market by Indication: Key Takeaways
• Fig. 48 Veterinary Renal Disease Market by Indication, Market Share, 2024 & 2030
• Fig. 49 Renal Failure Market, 2018 - 2030 (USD Billion)
• Fig. 50 Chronic Kidney Disease (CKD) Market, 2018 - 2030 (USD Billion)
• Fig. 51 Renal Cystitis market, 2018 - 2030 (USD Billion)
• Fig. 52 Kidney Stones market, 2018 - 2030 (USD Billion)
• Fig. 53 Neprhritis market, 2018 - 2030 (USD Billion)
• Fig. 54 Others market, 2018 - 2030 (USD Billion)
• Fig. 55 Veterinary Renal Disease Market by Distribution Channel: Key Takeaways
• Fig. 56 Veterinary Renal Disease Market by Distribution Channel, Market Share, 2024 & 2030
• Fig. 57 Veterinary Hospitals & Clinics Market, 2018 - 2030 (USD Billion)
• Fig. 58 Pet Specialty Stores Market, 2018 - 2030 (USD Billion)
• Fig. 59 E-Commerce market, 2018 - 2030 (USD Billion)
• Fig. 60 Others market, 2018 - 2030 (USD Billion)
• Fig. 61 Veterinary Renal Disease Market revenue, by region, 2024 & 2030 (USD Billion)
• Fig. 62 Regional market share analysis, 2024 & 2030
• Fig. 63 Regional marketplace: Key takeaways
• Fig. 64 Regional marketplace: Key takeaways
• Fig. 65 North America Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 66 Key country dynamics
• Fig. 67 U.S. Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 68 Key country dynamics
• Fig. 69 Canada Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 70 Key country dynamics
• Fig. 71 Mexico Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 72 Europe Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 73 Key country dynamics
• Fig. 74 UK Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 75 Key country dynamics
• Fig. 76 Germany Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 77 Key country dynamics
• Fig. 78 France Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 79 Key country dynamics
• Fig. 80 Italy Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 81 Key country dynamics
• Fig. 82 Spain Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 83 Key country dynamics
• Fig. 84 Denmark Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 85 Key country dynamics
• Fig. 86 Sweden Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 87 Key country dynamics
• Fig. 88 Norway Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 89 Key country dynamics
• Fig. 90 Asia Pacific Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 91 Key country dynamics
• Fig. 92 China Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 93 Key country dynamics
• Fig. 94 Japan Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 95 Key country dynamics
• Fig. 96 India Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 97 Key country dynamics
• Fig. 98 Australia Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 99 Key country dynamics
• Fig. 100 South Korea Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 101 Key country dynamics
• Fig. 102 Thailand Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 103 Latin America Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 104 Key country dynamics
• Fig. 105 Brazil Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 106 Key country dynamics
• Fig. 107 Argentina Veterinary Renal Disease Market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 108 MEA Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 109 Key country dynamics
• Fig. 110 South Africa Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 111 Key country dynamics
• Fig. 112 Saudi Arabia Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 113 Key country dynamics
• Fig. 114 UAE Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 115 Key country dynamics
• Fig. 116 Kuwait Veterinary Renal Disease Market, 2018 - 2030 (USD Billion)
• Fig. 117 Market Participant Categorization
• Fig. 118 Heat map analysis
• Fig. 119 Strategic Framework

Veterinary Renal Disease Market Growth & Trends:

The global veterinary renal disease market size is anticipated to reach USD 24.85 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 6.7% from 2025 to 2030. Rising prevalence of renal diseases coupled with adoption of therapeutic food as a treatment are key growth drivers for this market. Renal diseases like chronic kidney disease (CKD), renal failure, etc. cause irreversible damage to the renal system of animals. Despite no definite cure for this disease, proper management by various types of therapies can help in the betterment of animal life. One of the most prominent methods is that of nutritional management through therapeutic food.

Another crucial market propeller is the rising adoption of AI in veterinary renal disease diagnostics and treatment. Imaging plays a significant role in veterinary medicine by offering vital data for regular preventative measures as well as the assessment of disease and injury. AI can prove to be a very beneficial tool, especially in radiologist deficient geographies. Associated benefits such as faster and enhanced diagnostic capabilities is anticipated to increase adoption of AI and thereby influence positively on market in near future.

Mars Inc, which is a prominent player in the animal health space, has already stepped into the field of applying AI to veterinary diagnostics and treatment. Antech Diagnostics (Mars Inc.) introduced RenalTech, a cutting-edge diagnostic tool, in 2019. RenalTech uses artificial intelligence (AI) to evaluate pet medical record data and forecast a cat's risk of developing chronic kidney disease (CKD) up to two years ahead of an established clinical diagnosis.

Moreover, market dynamics such as product portfolio expansion, M&A, consolidation activities are further anticipated to provide growth platform to this market. For example, in September 2023, Elanco Animal Health received conditional U.S. FDA approval for Varenzin-CA1 (molidustat oral suspension), as the treatment to control non-regenerative anemia in cats with chronic kidney disease (CKD). Furthermore , in December 2023, Neogen Corporation partnered with the TerraNova Equestrian Center in Myakka City, Florida, making the company the official biosecurity provider of the facility for diagnostic testing products.

Veterinary Renal Disease Market Report Highlights:

• Based on type, the treatment segment led the market with the largest revenue share of 68.96% in 2024, due to the wide array of treatments available coupled with ever growing population of pets globally
• Based on animal type, the feline segment is expected to grow at the fastest CAGR over the forecast period
• Based on route of administration, the oral segment held the largest revenue share in 2024 and the injectable segment is expected to have the fastest CAGR over the forecast period
• Based on the indication, the renal cystitis segment held the largest revenue share of 29.05% in 2024 and nephritis segment is expected to have the second fastest CAGR over the forecast period
• Rising prevalence of a variety of renal complications in animals, prominent usage of pet food, growing disease awareness initiatives are contributing to the market growth
• North America accounted for the largest revenue share of the market in 2024. The increasing significance of animal health care in general throughout the region has been identified as a key factor propelling market expansion. The American Pet Products Association estimates that 65.1 million homes in the country have pets in 2023-2024. Moreover, growing pet owners' awareness of animal health and the significance of providing care for animals with renal disorders are fueling the market expansion in North America
• In May 2024, Dechra Pharmaceuticals announced distribution rights of two products to support kidney health in senior cats - Porus One, and Add One. Porus One contains renaltec, a selective absorber that soaks up precursors of uremia toxins in the cat's intestines that would ordinarily be removed or regulated by healthy kidneys. Add One is a moist cat treat designed for senior cats, developed to encourage them to eat Porus One, and is said to be useful for cats that prefer dry food

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates And Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis
  • 1.6.2. Global Market: CAGR Calculation
• 1.7. Research Scope and Assumptions
  • 1.7.1. List of Secondary Sources
  • 1.7.2. List of Primary Sources
  • 1.7.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Veterinary Renal Disease Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Increasing Prevalence of Renal Diseases
    • 3.2.1.2. Increase in Pet Ownership and Pet Expenditure
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High treatment cost
    • 3.2.2.2. Limited Access to New Technologies
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Veterinary Renal Disease Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining Power Of The Suppliers
    • 3.3.1.2. Bargaining Power Of The Buyers
    • 3.3.1.3. Threats Of Substitution
    • 3.3.1.4. Threats From New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal landscape
• 3.4. Pricing Analysis, 2024
• 3.5. Covid-19 Analysis

Chapter 4. Veterinary Renal Disease Market: Product Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Veterinary Renal Disease Market Movement Analysis
• 4.3. Global Veterinary Renal Disease Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Billion)
• 4.4. Diagnosis
  • 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 4.4.2. Test Kits & Consumables
    • 4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 4.4.3. Instruments
    • 4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 4.5. Treatment
  • 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 4.5.2. Drugs
    • 4.5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.5.2.2. NSAIDs
      • 4.5.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.5.2.3. Antibiotics
      • 4.5.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.5.2.4. Cystine-binding Agents
      • 4.5.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.5.2.5. Diuretics
      • 4.5.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.5.2.6. Others
      • 4.5.2.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 4.5.3. Therapeutic Food Supplements
    • 4.5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 4.5.4. Ringer Lactate Solution
    • 4.5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Veterinary Renal Disease Market: Animal Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Veterinary Renal Disease Market Movement Analysis
• 5.3. Global Veterinary Renal Disease Market Size & Trend Analysis, by Animal Type, 2018 to 2030 (USD Billion)
• 5.4. Canine
  • 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 5.5. Feline
  • 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 5.6. Bovine
  • 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 5.7. Equine
  • 5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 5.8. Others
  • 5.8.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Veterinary Renal Disease Market: Route of Administration Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Veterinary Renal Disease Market Movement Analysis
• 6.3. Global Veterinary Renal Disease Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Billion)
• 6.4. Oral
  • 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 6.5. Injectable
  • 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Veterinary Renal Disease Market: Indication Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Veterinary Renal Disease Market Movement Analysis
• 7.3. Global Veterinary Renal Disease Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Billion)
• 7.4. Renal Failure
  • 7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 7.5. Chronic Kidney Disease (CKD)
  • 7.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 7.6. Renal Cystitis
  • 7.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 7.7. Kidney Stones
  • 7.7.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 7.8. Neprhritis
  • 7.8.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 7.9. Others
  • 7.9.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Veterinary Renal Disease Market: Distribution Channel Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Veterinary Renal Disease Market Movement Analysis
• 8.3. Global Veterinary Renal Disease Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Billion)
• 8.4. Veterinary Hospitals & Clinics
  • 8.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 8.5. Pet Specialty Stores
  • 8.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 8.6. E-Commerce
  • 8.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 8.7. Others
  • 8.7.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Veterinary Renal Disease Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030 North America
• 9.3. North America
  • 9.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. U.S. Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Canada Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Mexico Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 9.4. Europe
  • 9.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 9.4.2. U.K.
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. U.K. Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Germany Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. France Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Italy Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Spain Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.4.7. Sweden
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Sweden Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.4.8. Denmark
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Denmark Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Norway Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 9.5. Asia Pacific
  • 9.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 9.5.2. China
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. China Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.5.3. Japan
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Japan Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. India Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.5.5. South Korea
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. South Korea Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.5.6. Australia
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Australia Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.5.7. Thailand
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Thailand Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 9.6. Latin America
  • 9.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Brazil Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Argentina Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 9.7. Middle East and Africa
  • 9.7.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Saudi Arabia Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.7.3. South Africa
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. South Africa Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. UAE Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Kuwait Veterinary Renal Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Company Market Position Analysis/ Heat Map Analysis
• 10.3. Estimated Company Market Share Analysis, 2024
• 10.4. Strategy Mapping
  • 10.4.1. Mergers & Acquisitions
  • 10.4.2. Partnerships & Collaborations
  • 10.4.3. Others
• 10.5. Company Profiles
  • 10.5.1. Mars, Incorporated
    • 10.5.1.1. Participant's Overview
    • 10.5.1.2. Financial Performance
    • 10.5.1.3. Product Type Benchmarking
    • 10.5.1.4. Strategic Initiatives
  • 10.5.2. Nestle Purina PetCare
    • 10.5.2.1. Participant's Overview
    • 10.5.2.2. Financial Performance
    • 10.5.2.3. Product Type Benchmarking
    • 10.5.2.4. Strategic Initiatives
  • 10.5.3. Arkray
    • 10.5.3.1. Participant's Overview
    • 10.5.3.2. Financial Performance
    • 10.5.3.3. Product Type Benchmarking
    • 10.5.3.4. Strategic Initiatives
  • 10.5.4. General Mills
    • 10.5.4.1. Participant's Overview
    • 10.5.4.2. Financial Performance
    • 10.5.4.3. Product Type Benchmarking
    • 10.5.4.4. Strategic Initiatives
  • 10.5.5. Zoetis Inc.
    • 10.5.5.1. Participant's Overview
    • 10.5.5.2. Financial Performance
    • 10.5.5.3. Product Type Benchmarking
    • 10.5.5.4. Strategic Initiatives
  • 10.5.6. Merck & Co., Inc.
    • 10.5.6.1. Participant's Overview
    • 10.5.6.2. Financial Performance
    • 10.5.6.3. Product Type Benchmarking
    • 10.5.6.4. Strategic Initiatives
  • 10.5.7. Elanco
    • 10.5.7.1. Participant's Overview
    • 10.5.7.2. Financial Performance
    • 10.5.7.3. Product Type Benchmarking
    • 10.5.7.4. Strategic Initiatives
  • 10.5.8. Bionote U.S.A
    • 10.5.8.1. Participant's Overview
    • 10.5.8.2. Financial Performance
    • 10.5.8.3. Product Type Benchmarking
    • 10.5.8.4. Strategic Initiatives
  • 10.5.9. Ceva Sante Animale
    • 10.5.9.1. Participant's Overview
    • 10.5.9.2. Financial Performance
    • 10.5.9.3. Product Type Benchmarking
    • 10.5.9.4. Strategic Initiatives
  • 10.5.10. Boehringer Ingelheim International GmbH.
    • 10.5.10.1. Participant's Overview
    • 10.5.10.2. Financial Performance
    • 10.5.10.3. Product Type Benchmarking
    • 10.5.10.4. Strategic Initiatives
  • 10.5.11. Dechra Pharmaceuticals PLC
    • 10.5.11.1. Participant's Overview
    • 10.5.11.2. Financial Performance
    • 10.5.11.3. Product Type Benchmarking
    • 10.5.11.4. Strategic Initiatives
  • 10.5.12. Vedco Inc.
    • 10.5.12.1. Participant's Overview
    • 10.5.12.2. Financial Performance
    • 10.5.12.3. Product Type Benchmarking
    • 10.5.12.4. Strategic Initiatives
  • 10.5.13. Mission Pharmacal Company
    • 10.5.13.1. Participant's Overview
    • 10.5.13.2. Financial Performance
    • 10.5.13.3. Product Type Benchmarking
    • 10.5.13.4. Strategic Initiatives
  • 10.5.14. Neogen Corporation
    • 10.5.14.1. Participant's Overview
    • 10.5.14.2. Financial Performance
    • 10.5.14.3. Product Type Benchmarking
    • 10.5.14.4. Strategic Initiatives
  • 10.5.15. IDEXX Laboratories, Inc.
    • 10.5.15.1. Participant's Overview
    • 10.5.15.2. Financial Performance
    • 10.5.15.3. Product Type Benchmarking
    • 10.5.15.4. Strategic Initiatives

Chapter 11. Key Takeaways